Two separate reports claim that Amazon has settled its two EU antitrust cases and agreed to behavioral changes that will prevent future abuses. The settlement will be announced on December 20.
The settlement will require Amazon to give rival sellers of products equal access to its dominant online storefront as its own, Amazon-branded products. It will prevent Amazon from using the private data it acquires about third-party sellers to decide which products to copy and sell under the Amazon brand. And it lets independent sellers participate in Amazon’s Prime program without being forced to use Amazon’s logistics business. (That latter change has echoes of the in-app purchase probes that both Apple and Google face.)
Amazon will not pay a financial penalty, but it avoids several years of litigation, billions of dollars in legal costs, and annual fines of up to 10 percent of its global revenues.
Related: NGOs Say EU Amazon Antitrust Probe Has Many Issues
The New York Times, which is one of the high-profile sources for this information, notes that the Amazon settlement could serve as a preview of similar upcoming changes at Apple, Google, and Meta, each of which faces various EU investigations of their own. The publication cites three people with knowledge of the deal.
News of the settlement was first reported by the Financial Times, which said that the final deal closely follows the language of a draft proposal from this past summer.
According to the reports, the agreement covers only the EU, of course, though Amazon could proactively choose to avoid antitrust entanglements in the US and elsewhere by adopting it globally; California, for example, has already sued Amazon for the same reasons. The EU agreement will be in effect for five years.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan